Medicine shortages have eased considerably in 2025, dropping by about a third compared with 2024, according to a report from healthcare consultancy SiRM. Prepared for the industry group BG Pharma, the report suggests a turning point in the persistent challenges with drug availability.The most notable improvements were in medicines where wholesalers had increased stock, including commonly used drugs like painkillers and blood pressure medications.